{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:48:31Z","timestamp":1790948911076,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.intimp.2023.110017","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T14:04:42Z","timestamp":1678889082000},"page":"110017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparative transcriptome profile of mouse macrophages treated with the RhoA\/Rock pathway inhibitors Y27632, Fingolimod (Gilenya), and Rezurock (Belumosudil, SLx-2119)"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8777-9533","authenticated-orcid":false,"given":"Arijita","family":"Subuddhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Uosef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry V.","family":"Ubelaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafik M.","family":"Ghobrial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5192-8584","authenticated-orcid":false,"given":"Malgorzata","family":"Kloc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110017_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2321-3868.121646","article-title":"Chronic allograft rejection: a significant hurdle to transplant success","volume":"2","author":"Kloc","year":"2014","journal-title":"Burns Trauma."},{"key":"10.1016\/j.intimp.2023.110017_b0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-3-319-54090-0_15","article-title":"Macrophages and RhoA pathway in transplanted organs","volume":"62","author":"Liu","year":"2017","journal-title":"Results Probl. Cell Differ."},{"key":"10.1016\/j.intimp.2023.110017_b0015","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/TP.0b013e31828d1528","article-title":"Histopathology of chronic rejection in a nonhuman primate model of vascularized composite allotransplantation","volume":"95","author":"Mundinger","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2023.110017_b0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.amjms.2021.01.013","article-title":"Decline in publications on chronic rejection and graft vascular disease: a matter of concern","volume":"362","author":"Subbotin","year":"2021","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.intimp.2023.110017_b0025","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/EBC20190015","article-title":"Actin dynamics in cell migration","volume":"63","author":"Schaks","year":"2019","journal-title":"Essays Biochem."},{"key":"10.1016\/j.intimp.2023.110017_b0030","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1002\/jcp.26487","article-title":"Regulation of RhoA GTPase and various transcription factors in the RhoA pathway","volume":"233","author":"Kim","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2023.110017_b0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biocel.2017.10.009","article-title":"Rho-specific Guanine nucleotide exchange factors (Rho-GEFs) inhibition affects macrophage phenotype and disrupts Golgi complex","volume":"93","author":"Chen","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.intimp.2023.110017_b0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.healun.2016.08.011","article-title":"Macrophage\/monocyte-specific deletion of Ras homolog gene family member A (RhoA) downregulates fractalkine receptor and inhibits chronic rejection of mouse cardiac allografts","volume":"36","author":"Liu","year":"2017","journal-title":"J. Heart Lung Transplant"},{"issue":"10","key":"10.1016\/j.intimp.2023.110017_b0045","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/CIRCULATIONAHA.110.005249","article-title":"Donor simvastatin treatment abolishes rat cardiac allograft ischemia\/reperfusion injury and chronic rejection through microvascular protection","volume":"124","author":"Tuuminen","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2023.110017_b0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.trim.2018.06.002","article-title":"Screening RhoA\/ROCK inhibitors for the ability to prevent chronic rejection of mouse cardiac allografts","volume":"50","author":"Chen","year":"2018","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.intimp.2023.110017_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2020.101347","article-title":"Fingolimod (FTY720) prevents chronic rejection of rodent cardiac allografts through inhibition of the RhoA pathway","volume":"65","author":"Chen","year":"2021","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.intimp.2023.110017_b0060","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1200\/JCO.20.02754","article-title":"ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease","volume":"39","author":"Jagasia","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2023.110017_b0065","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/eye.2016.258","article-title":"Fingolimod: therapeutic mechanisms and ocular adverse effects","volume":"31","author":"Mandal","year":"2017","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.intimp.2023.110017_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.607968","article-title":"Simvastatin and ROCK inhibitor Y-27632 inhibit myofibroblast differentiation of graves' ophthalmopathy-derived orbital fibroblasts via RhoA-mediated ERK and p38 signaling pathways","volume":"11","author":"Wei","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.intimp.2023.110017_b0075","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1053-2498(01)00292-3","article-title":"A highly selective inhibitor of Rho-associated coiled-coil forming protein kinase, Y-27632, prolongs cardiac allograft survival of the BALB\/c-to-C3H\/He mouse model","volume":"20","author":"Ohki","year":"2001","journal-title":"J. Heart Lung Transpl."},{"key":"10.1016\/j.intimp.2023.110017_b0080","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.110017_b0085","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbadis.2012.12.007","article-title":"Strategies for anti-fibrotic therapies","volume":"1832","author":"Rosenbloom","year":"2013","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.intimp.2023.110017_b0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2014.09.006","article-title":"Markers of fibrosis, inflammation, and remodeling pathways in heart failure","volume":"443","author":"Passino","year":"2015","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.intimp.2023.110017_b0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0070-2153(10)92002-4","article-title":"Mechanistic insights into Notch receptor signaling from structural and biochemical studies","volume":"92","author":"Kovall","year":"2010","journal-title":"Curr. Top Dev. Biol."},{"key":"10.1016\/j.intimp.2023.110017_b0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.phrs.2016.04.010","article-title":"Notch in fibrosis and as a target of anti-fibrotic therapy","volume":"108","author":"Hu","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2023.110017_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0228-0","article-title":"Notch1 promotes the pericyte-myofibroblast transition in idiopathic pulmonary fibrosis through the PDGFR\/ROCK1 signal pathway","volume":"51","author":"Wang","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2023.110017_b0110","doi-asserted-by":"crossref","unstructured":"Julius BK, Attenhofer Jost CH, S\u221a\u00b0tsch G, Brunner HP, Kuenzli A, Vogt PR, Turina M, Hess OM, Kiowski W. Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation. Transplantation. 2000; 69:847-53. doi: 10.1097\/00007890-200003150-00030.","DOI":"10.1097\/00007890-200003150-00030"},{"key":"10.1016\/j.intimp.2023.110017_b0115","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2023.110017_b0120","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/14737159.2016.1239530","article-title":"Advances in diagnostics for transplant rejection","volume":"16","author":"Nasr","year":"2016","journal-title":"Exp. Rev. Mol. Diagn."},{"key":"10.1016\/j.intimp.2023.110017_b0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/08830185.2016.1225300","article-title":"Renal transplant immunology in the last 20 years: a revolution towards graft and patient survival improvement","volume":"36","author":"S\u00e1","year":"2017","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110017_b0130","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1126\/science.285.5429.895","article-title":"Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase","volume":"285","author":"Maekawa","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.intimp.2023.110017_b0135","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrm1128","article-title":"Rocks: multifunctional kinases in cell behaviour","volume":"4","author":"Riento","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2023.110017_b0140","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1074\/jbc.M211584200","article-title":"RhoA and ROCK promote migration by limiting membrane protrusions","volume":"278","author":"Worthylake","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2023.110017_b0145","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1152\/physrev.00003.2005","article-title":"Mammalian G proteins and their cell type specific functions","volume":"85","author":"Wettschureck","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2023.110017_b0150","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1016\/j.jmb.2016.08.002","article-title":"Regulation, signaling, and physiological functions of G-proteins","volume":"428","author":"Syrovatkina","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.intimp.2023.110017_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103745","article-title":"Elevated Wnt2 and Wnt4 activate NF-\u0152\u222bB signaling to promote cardiac fibrosis by cooperation of Fzd4\/2 and LRP6 following myocardial infarction","volume":"74","author":"Yin","year":"2021","journal-title":"EBioMedicine."},{"key":"10.1016\/j.intimp.2023.110017_b0160","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1210\/me.2012-1322","article-title":"PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV","volume":"27","author":"Rider","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.intimp.2023.110017_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152949","article-title":"Qishen granule attenuates cardiac fibrosis by regulating TGF-\u0152\u2264 \/Smad3 and GSK-3\u0152\u2264 pathway","volume":"62","author":"Zeng","year":"2019","journal-title":"Phytomedicine."},{"issue":"10","key":"10.1016\/j.intimp.2023.110017_b0170","first-page":"491","article-title":"Sildenafil counteracts the in vitro activation of CXCL-9, CXCL-10 and CXCL-11\/CXCR3 axis induced by reactive oxygen species in scleroderma fibroblasts","volume":"2021","author":"Antinozzi","year":"2021","journal-title":"Biology (Basel)."},{"key":"10.1016\/j.intimp.2023.110017_b0175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.intimp.2023.110017_b0180","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/ijms21051872","article-title":"Tumor-cell-macrophage fusion cells as liquid biomarkers and tumor enhancers in cancer","volume":"21","author":"Manjunath","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.intimp.2023.110017_b0185","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1186\/s12885-015-1935-0","article-title":"Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction","volume":"2015","author":"Shabo","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2023.110017_b0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2023.110017_b0195","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/ijms19010092","article-title":"The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis","volume":"19","author":"Hirayama","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.110017_b0200","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2023.110017_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102833","article-title":"Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients","volume":"57","author":"Wang","year":"2020","journal-title":"EBioMedicine."},{"key":"10.1016\/j.intimp.2023.110017_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102437","article-title":"The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients","volume":"45","author":"Kloc","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.intimp.2023.110017_b0215","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110017_b0220","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/intimm\/dxy054","article-title":"Macrophages in inflammation, repair and regeneration","volume":"30","author":"Oishi","year":"2018","journal-title":"Int Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923003387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923003387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:02:30Z","timestamp":1761588150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923003387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":44,"alternative-id":["S1567576923003387"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110017","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative transcriptome profile of mouse macrophages treated with the RhoA\/Rock pathway inhibitors Y27632, Fingolimod (Gilenya), and Rezurock (Belumosudil, SLx-2119)","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110017"}}